Importance of apical membrane delivery of 1,25-dihydroxyvitamin D3 to vitamin D-responsive gene expression in the colon

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 303, Issue 7, 2012, Pages

  Koszewski, Nicholas J ^a   Horst, Ronald L ^b   Goff, Jesse P ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b Heartland Assays Inc   (United States)

Author keywords

Intestine; RNA; Transcription

Indexed keywords

BETA 25 MONOGLUCURONIDE 1,25 DIHYDROXYVITAMIN D 3; BETA GLUCURONIDASE; CALCITRIOL; OXYGENASE; PROTEIN CYP24A1; UNCLASSIFIED DRUG; VITAMIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON; CONTROLLED STUDY; DOSE RESPONSE; DUODENUM; ENZYME ACTIVITY; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MOUSE; NONHUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; STRUCTURE ACTIVITY RELATION; UPREGULATION; VITAMIN BLOOD LEVEL; VITAMIN D RESPONSIVE ELEMENT;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CALCITRIOL; CALCIUM; COLON; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GLUCURONIDES; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED C57BL; RATS; RATS, SPRAGUE-DAWLEY; STEROID HYDROXYLASES; VITAMINS;

EID: 84867186139     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00149.2012     Document Type: Article

References (55)

1. Akeno N, Saikatsu S, Kawane T, Horiuchi N. Mouse vitamin D-24- hydroxylase: molecular cloning, tissue distribution, and transcriptional regulation by 1α,25-dihydroxyvitamin D3. Endocrinology 138: 2233-2240, 1997.
2. Baeke F, van Etten E, Gysemans C, Overbergh L, Mathieu C. Vitamin D signaling in immune-mediated disorders: evolving insights and therapeutic opportunities. Mol Aspects Med 29: 376-387, 2008.
3. 3-1α-hydroxylase expression in normal and malignant human colon. J Histochem Cytochem 52: 985-989, 2004.
4. Cantorna MT, Munsick C, Bemiss C, Mahon BD. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 130: 2648-2652, 2000.
5. 3 stimulates activator protein-1-dependent Caco-2 cell differentiation. J Biol Chem 274: 35505-35513, 1999.
6. Cheng YH, Goff JP, Sell JL, Dallorso ME, Gil S, Pawlak SE, Horst RL. Utilizing Solanum glaucophyllum alone or with phytase to improve phosphorus utilization in broilers. Poult Sci 83: 406-413, 2004.
7. Christakos S, Dhawan P, Porta A, Mady LJ, Seth T. Vitamin D and intestinal calcium absorption. Mol Cell Endocrinol 347: 25-29, 2011.
8. Clements MR, Chalmers TM, Fraser DR. Enterohepatic circulation of vitamin D: a reappraisal of the hypothesis. Lancet 1: 1376-1379, 1984.
9. 3-relevance for colonic cancer prevention and therapy. Mol Aspects Med 24: 459-465, 2003.
10. Cross HS, Nittke T, Peterlik M. Modulation of vitamin D synthesis and catabolism in colorectal mucosa: a new target for cancer prevention. Anticancer Res 29: 3705-3712, 2009.
11. Das A, Spackman E, Pantin-Jackwood MJ, Suarez DL. Removal of real-time reverse transcription polymerase chain reaction (RT-PCR) inhibitors associated with cloacal swab samples and tissues for improved diagnosis of avian influenza virus by RT-PCR. J Vet Diagn Invest 21: 771-778, 2009.
12. 3 concentrations and incident sporadic colorectal adenoma risk: a pooled case-control study. Am J Epidemiol 172: 489-500, 2010.
13. Fichera A, Little N, Dougherty U, Mustafi R, Cerda S, Li YC, Delgado J, Arora A, Campbell LK, Joseph L, Hart J, Noffsinger A, Bissonnette M. A vitamin D analogue inhibits colonic carcinogenesis in the AOM/ DSS model. J Surg Res 142: 239-245, 2007.
14. 3 as a therapeutic agent for androgen-dependent prostate cancer. Anticancer Res 29: 3547-3553, 2009.
15. Fleet JC, DeSmet M, Johnson R, Li Y. Vitamin D and cancer: a review of molecular mechanisms. Biochem J 441: 61-76, 2012.
16. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9: 227-231, 1980.
17. 3 in the vitamin D-depleted rat. Am J Physiol Gastrointest Liver Physiol 242: G522-G532, 1982.
18. Giardina C, Madigan JP, Tierney CA, Brenner BM, Rosenberg DW. Vitamin D resistance and colon cancer prevention. Carcinogenesis 33: 475-482, 2012.
19. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25: 386-401, 2001.
20. Goff JP, Koszewski NJ, Haynes JS, Horst RL. Targeted delivery of vitamin D to the colon using β-glucuronides of vitamin D: therapeutic effects in a murine model of inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 302: G460-G469, 2012.
21. Goff JP, Reinhardt TA, Engstrom GW, Horst RL. Effect of dietary calcium or phosphorus restriction and 1,25-dihydroxyvitamin D administration on rat intestinal 24-hydroxylase. Endocrinology 131: 101-104, 1992.
22. Gulliford T, English J, Colston KW, Menday P, Moller S, Coombes RC. A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer. Br J Cancer 78: 6-13, 1998.
23. Harris DM, Go VL. Vitamin D and colon carcinogenesis. J Nutr 134: 3463S-3471S, 2004.
24. 3 conjugation. Biochem Pharmacol 75: 1240-1250, 2008.
25. 3. Steroids 65: 281-294, 2000.
26. Holick MF. Vitamin D and sunlight: strategies for cancer prevention and other health benefits. Clin J Am Soc Nephrol 3: 1548-1554, 2008.
27. Hollis BW. Quantitation of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers. Methods Enzymol 282: 174-186, 1997.
28. 2D: where we are and where we are going. J Steroid Biochem Mol Biol 103: 473-476, 2007.
29. Horvath HC, Lakatos P, Kosa JP, Bacsi K, Borka K, Bises G, Nittke T, Hershberger PA, Speer G, Kallay E. The candidate oncogene CYP24A1: a potential biomarker for colorectal tumorigenesis. J Histochem Cytochem 58: 277-285, 2010.
30. min mouse. Cancer Res 62: 741-746, 2002.
31. Jenab M, Bueno-de-Mesquita HB, Ferrari P, van Duijnhoven FJ, Norat T, Pischon T, Jansen EH, Slimani N, Byrnes G, Rinaldi S, Tjonneland A, Olsen A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Kaaks R, Linseisen J, Boeing H, Bergmann MM, Trichopoulou A, Misirli G, Trichopoulos D, Berrino F, Vineis P, Panico S, Palli D, Tumino R, Ros MM, van Gils CH, Peeters PH, Brustad M, Lund E, Tormo MJ, Ardanaz E, Rodriguez L, Sanchez MJ, Dorronsoro M, Gonzalez CA, Hallmans G, Palmqvist R, Roddam A, Key TJ, Khaw KT, Autier P, Hainaut P, Riboli E. Association between prediagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study. BMJ 340: b5500, 2010.
32. Jimenez-Lara AM. Colorectal cancer: potential therapeutic benefits of vitamin D. Int J Biochem Cell Biol 39: 672-677, 2007.
33. 3 treatment in Crohn's disease-a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther 32: 377-383, 2010.
34. 3 are differently modified by 9-cis-retinoic acid. Cancer Res 56: 623-632, 1996.
35. Kong J, Zhang Z, Musch MW, Ning G, Sun J, Hart J, Bissonnette M, Li YC. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 294: G208-G216, 2008.
36. 3. J Clin Invest 65: 277-284, 1980.
37. Ma Y, Zhang P, Wang F, Yang J, Liu Z, Qin H. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol 29: 3775-3782, 2011.
38. Murillo G, Nagpal V, Tiwari N, Benya RV, Mehta RG. Actions of vitamin D are mediated by the TLR4 pathway in inflammation-induced colon cancer. J Steroid Biochem Mol Biol 121: 403-407, 2010.
39. Nagubandi S, Kumar R, Londowski JM, Corradino RA, Tietz PS. Role of vitamin-D glucosiduronate in calcium homeostasis. J Clin Invest 66: 1274-1280, 1980.
40. Newmark HL, Yang K, Kurihara N, Fan K, Augenlicht LH, Lipkin M. Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis 30: 88-92, 2009.
41. Norman AW. The vitamin D endocrine system: manipulation of structure-function relationships to provide opportunities for development of new cancer chemopreventive and immunosuppressive agents. J Cell Biochem Suppl 22: 218-225, 1995.
42. Peng JB, Chen XZ, Berger UV, Vassilev PM, Tsukaguchi H, Brown EM, Hediger MA. Molecular cloning and characterization of a channellike transporter mediating intestinal calcium absorption. J Biol Chem 274: 22739-22746, 1999.
43. Peyrin-Biroulet L, Oussalah A, Bigard MA. Crohn's disease: the hot hypothesis. Med Hypotheses 73: 94-96, 2009.
44. Rambeck WA, Weiser H, Meier W, Labler L, Zucker H. Biological activity of the 3 mono-β-D-glucopyranosides of 1,25-dihydroxycholecalciferol. Int J Vitam Nutr Res 55: 263-267, 1985.
45. Smith DC, Johnson CS, Freeman CC, Muindi J, Wilson JW, Trump DL. A phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy. Clin Cancer Res 5: 1339-1345, 1999.
46. Spina C, Tangpricha V, Yao M, Zhou W, Wolfe MM, Maehr H, Uskokovic M, Adorini L, Holick MF. Colon cancer and solar ultraviolet B radiation and prevention and treatment of colon cancer in mice with vitamin D and its Gemini analogs. J Steroid Biochem Mol Biol 97: 111-120, 2005.
47. Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, Holt PR, Lipkin MS, Holick MF. 25-Hydroxyvitamin D-1α-hydroxylase in normal and malignant colon tissue. Lancet 357: 1673-1674, 2001.
48. Taparia S, Fleet JC, Peng JB, Wang XD, Wood RJ. 1,25-Dihydroxyvitamin D and 25-hydroxyvitamin D-mediated regulation of TRPV6 (a putative epithelial calcium channel) mRNA expression in Caco-2 cells. Eur J Nutr 45: 196-204, 2006.
49. Thieler S, Scholmerich J. [Gastrointestinal diseases and osteomalacia]. Internist (Berl) 49: 1197-1198, 1200, 1202-1195, 2008.
50. 3-24-hydroxylase activity in Caco-2 cells. An in vitro model of intestinal vitamin D catabolism. Endocrinology 126: 2868-2875, 1990.
51. Welsh J. Cellular and molecular effects of vitamin D on carcinogenesis. Arch Biochem Biophys 523: 107-114, 2012.
52. 3 metabolites in normal man. J Lab Clin Med 96: 1094-1100, 1980.
53. MIN modulation of vitamin D secosteroid growth control. Carcinogenesis 31: 1434-1441, 2010.
54. Xue Y, Fleet JC. Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice. Gastroenterology 136: 1317-1327, e1311-e1312, 2009.
55. Zhao X, Feldman D. Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells. Endocrinology 132: 1808-1814, 1993.